Patents by Inventor Ji-Hyun GO

Ji-Hyun GO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240245692
    Abstract: A pharmaceutical composition containing a compound of Formula 1 or Formula 2 below or a pharmaceutically acceptable salt thereof. The composition is suitable for preventing or treating RON-mutation-associated biliary tract cancer. The pharmaceutical composition can be applied to a biliary tract cancer patient having a RON mutation. Particularly, the pharmaceutical composition can be effectively used for treating a biliary tract cancer patient who is resistant to cetuximab, which is conventionally used for cancer treatment, and who has mutation at RONA 155, RON?160 or RON?165.
    Type: Application
    Filed: May 3, 2022
    Publication date: July 25, 2024
    Applicant: WELLMARKER BIO CO., LTD.
    Inventors: Seung-Mi KIM, Yeon-Seoung CHOI, Ha-Neul LEE, Ji-Hyun GO, Eun-Hee KO, Yu-Geun JI
  • Publication number: 20230346790
    Abstract: A pharmaceutical composition for preventing or treating cancer, which is associated with a KRAS mutation and exhibits resistance to an EGFR-targeted therapeutic agent is disclosed. The pharmaceutical composition can be useful for treatment of patients with cancer which has the KRAS mutation and exhibits resistance to cetuximab that is an anticancer therapeutic agent. A method for providing information on an anticancer treatment and/or enhancing cancer treatment by identifying a KRAS mutation and optionally additionally a RON mutation are disclosed.
    Type: Application
    Filed: February 5, 2021
    Publication date: November 2, 2023
    Applicant: WELLMARKER BIO CO., LTD.
    Inventors: Jae-Sik SHIN, Jung-Eun LEE, Joon-Yee JEONG, Min-Ki LEE, Hyo-Jin KIM, Soon-Jin CHOI, Ji-Hyun GO